Sentinel lymph node mapping opens a new perspective in the surgical management of early-stage breast cancer: A combined approach with vital blue dye lymphatic mapping and radioguided surgery

Seminars in Surgical Oncology

Volumn 15, Issue 4, 1998, Pages 272-277

  Canavese, Giuseppe ^a   Gipponi, Marco ^a   Catturich, Alessandra ^a   Di Somma, Carmine ^a   Vecchio, Carlo ^a   Rosato, Francesco ^a   Tomei, Daniela ^a   Cafiero, Ferdinando ^b   Moresco, Luciano ^b   Nicolò, Guido ^a   Carli, Franca ^a   Villa, Giuseppe ^b   Buffoni, Ferdinando ^b   Badellino, Fausto ^c  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c Pathology Laboratory Ist Naz per la Ricerca sul Cancro ^*

Author keywords

Axilla; Biopsy; Breast neoplasms; False negative reactions; Intraoperative period; Lymph node excision; Lymph nodes radionuclide imaging pathology; Lymphatic metastasis; Melanoma; Neoplasm recurrence; Neoplasm staging; Predictive value of tests; Radioimmunodetection; Rosaniline dyes; Sensitivity and specificity; Staining; Technetium compounds

Indexed keywords

ALBUMIN TC 99M; ALBURES; DISULFINE BLUE; LYMPHOSCINT; SERUM ALBUMIN; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ADULT; AGED; AXILLARY LYMPH NODE; BREAST CANCER; CANCER LOCALIZATION; CANCER STAGING; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHATIC DRAINAGE; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MICROSCOPY; PRIORITY JOURNAL; RADIOSURGERY; STAINING;

EID: 7844247962     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2388(199812)15:4<272::AID-SSU17>3.0.CO;2-I     Document Type: Conference Paper

References (39)

1. Burke HB, Mutter RV, Henson DE: Breast carcinoma. In: Hermanek P, Gospodarowicz MK, Henson DE, et al (eds): "Prognostic factors in cancer." Berlin: Springer: 1995. p. 165-176.
2. Canavese G, Cattunch A, Vecchio C, et al: Prognostic role of lymphnode level involvement in patients undergoing axillary dissection for breast cancer. Eur J Surg Oncol 1998;24:104-109.
3. Hladiuk M, Huchcroft S, Temple W, Schnurr BE: Arm function after axillary dissection for breast cancer: a pilot study to provide parameters estimates. J Surg Oncol 1992;50:47-52.
4. Ivens D, Hoe AL, Podd TJ, et al: Assessment of morbidity from complete axillary dissection. Br J Cancer 1992;66:136-138.
5. Maunsell E, Brisson J, Deshenes L: Arm problems and psychological distress after surgery for breast cancer. Can J Surg 1993; 36; 315-320.
6. Recht A, Houlihan MJ: Axillary lymph nodes and breast cancer: a review [Review]. Cancer 1995;76:1491-1512.
7. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group [Review][comment in: Lancet 1992;339(8790):423-424]. Lancet 1992;339(8790):1-15.
8. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy, 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group [Review][comment in: Lancet 1992;339(8790):423-424]. Lancet 1992;339(8785):71-85.
9. Goldhirsch A, Wood WC, Senn HJ,et al: Meeting highlights: international consensus panel on the treatment of primary breast cancer. J Natl Cancer Inst 1995;87:1441-1445.
10. th annual meeting;1998 May 16-18; Los Angeles (CA). ASCO Educational Book; Spring 1998:132-141.
11. Fisher B, Redmond C, Fisher ER, et al: Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985;312: 674-681.
12. st World Congress of Surgical Oncology; 26-29 March 1998; San Diego, CA. Arlington Heights (IL): Society of Surgical Oncology; 1998:7.
13. Uren RF, Howman-Giles RB, Thompson JF, et al: Mammary lymphoscintigraphy in breast cancer [comment in: J Nucl Med 1995;36:1780-1783]. J Nucl Med 1995;36:1775-1780.
14. De Cicco C, Cremonesi M, Chinol M, et al: Optimization of axillary lymphoscintigraphy to detect the sentinel node in breast cancer. Tumori 1997;83:539-541.
15. th ed. Berlin: Springer-Verlag; 1997.
16. Boova Rs, Bonanni R, Rosato FE: Patterns of axillary nodal involvement in breast cancer. Predictability of level one dissection. Ann Surg 1982;196:642-644.
17. Rosen PP, Lesser ML, Kinne DW, Beattie EJ: Discontinuous or "skip" metastases in breast carcinoma Analysis of 1228 axillary dissections. Ann Surg 1983;97:276-283.
18. Pigott J, Nichols R, Maddox WA, Balch C: Metastases to the upper levels of the axillary nodes in carcinoma of the breast and its implications for nodal sampling procedures. Surg Gynecol Obstet 1984;158:255-259.
19. Steele RJ, Forrest AP, Gibson T, et al: The efficacy of lower axillary sampling in obtaining lymph node status in breast cancer: a controlled randomized trial. Br J Surg 1985;72:368-369.
20. Veronesi U, Rilke F, Luini A, et al: Distribution of axillary node metastases by level of invasion. An analysis of 539 cases. Cancer 1986;59:682-687.
21. Veronesi U, Luini A, Galimberti V, et al: Extent of metastatic axillary involvement in 1446 cases of breast cancer. Eur J Surg Oncol 1990;16:127-133.
22. Krag DN, Weaven DL, Alex JC, Fairbank JT: Surgical resection and radiolocalization of the sentinel node in breast cancer using a gamma probe. Surg Oncol 1993;2:335-340.
23. Giuliano AE, Kirgan DM, Guenther JM, Morton DL: Lymphatic mapping and sentinel lymphadenectomy for breast cancer [comment in: Ann Surg 1997;225:126-127]. Ann Surg 1994;220:391-401.
24. Albertini JJ, Lyman GH, Cox C, et al: Lymphatic mapping and sentinel node biopsy in the patient with breast cancer [comment in: JAMA 1997;227:791-792]. JAMA 1996;276:1818-1822.
25. Veronesi U, Paganelli G, Galimberti V, et al: Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes [comment in: Lancet 1997;350(9080):808-809]. Lancet 1997;349(9069):1864-1867.
26. Giuliano AE, Jones RC, Brennan M, Statman R: Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2345-2350.
27. Barnwell JM, Arredondo MA, Kollmorgen D, et al: Sentinel node biopsy in breast cancer. Ann Surg Oncol 1998;5:126-130.
28. Canavese G, Gipponi M, Catturich A, et al: Lymphatic mapping and sentinel lymph node biopsy in operable breast cancer. J Exp Clin Cancer Res 1997;16:66.
29. Giuliano AE, Dale PS, Turner RR, et al: Improved axillary staging of breast cancer with sentinel lymphadenectomy [Review] [comment in: Ann Surg 1997;225:126-127]. Ann Surg 1995;222:394-401.
30. Moss TJ, Reynolds CP, Sather HN, et al: Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma. N Engl J Med 1991;324:219-226.
31. Moreno JG, Crose CM, Fischer R, et al: Detection of hematogenous micrometastases in patients with prostate cancer. Cancer Res 1992;52.6110-6112.
32. Greenson JK, Isenhart CE, Rice R, et al: Identification of occult micrometastases in pericolic lymph nodes of Dukes' B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival Cancer 1994;73:563-569.
33. Maehara Y, Oshiro T, Endo K, et al: Clinical significance of occult micrometastases in lymph nodes from patients with early gastric cancer who died of recurrence. Surgery 1996;119:397-402.
34. Ross MI: Surgical management of Stage I and II melanoma patients: approach to the regional lymph node basin. Semin Surg Oncol 1996;12:394-401.
35. Silverstein MJ, Rosser RJ, Gierson ED, et al: Axillary lymph node dissection for intraductal carcinoma: is it indicated? Cancer 1987;59:1819-1824.
36. Balch CM, Singletary ES, Bland KI: Clinical decision-making in early breast cancer. Ann Surg 1993; 217:207-225.
37. Silverstein MJ, Gierson ED, Waisman JR, et al: Axillary lymph node dissection for Tla breast carcinoma: is it indicated? Cancer 1994;73:664-667
38. Greco M, Agresti R, Raselli R, et al.: Axillary dissection can be avoided in selected breast cancer patients. Analysis of 401 cases. Anticancer Res 1996,16:3913-3918.
39. Senofsky G, Moffat F, Davis K, et al: Total axillary lymphadenectomy in the management of breast cancer. Arch Surg 1991;126:1336-1342